Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ABS and Leading Korean Players Take Aim at Scope 3 Emissions Methodologies

(SEOUL) ABS is leading a unique approach to advance the shipbuilding industry’s decarbonization efforts with a joint development project (JDP) involving all the leading Korean shipyards plus the classification group Korean Register to address a growing need in the calculation of greenhouse gas (GHG) Scope 3 emissions. With key Korean shipyards HD Hyundai Group, Korea Shipbuilding & Offshore Engineering (KSOE), Hyundai Heavy Industries (HHI), Hyundai Mipo Dockyard (HMD), Hyundai Samho Heavy Industries (HSHI), Samsung Heavy Industries (SHI), and Daewoo Shipbuilding & Marine

North Holdings 3 Oy supplements the tender offer document relating to the public tender offer for all the shares in Caverion Corporation

Caverion Corporation   Tender Offer    17 March 2023 at 5.00 p.m. EETNorth Holdings 3 Oy supplements the tender offer document relating to the public tender offer for all the shares in Caverion Corporation NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. North Holdings 3 Oy supplements the tender offer document relating to the public tender offer for all the shares in Caverion

Hamlet Pharma’s achievements regarded as ‘‘exceptional’’ by the European Commission after final review of the Horizon 2020 project

Hamlet Pharma, listed on Spotlight Stock Market, was awarded an EIC Accelerator grant of 2.2 M EURO in the highly competitive Horizon 2020 program. The EIC accelerator program supports individual small and medium enterprises, in particular start ups and spin out companies, to develop and scale up game changing innovations. At the end of January 2023, Hamlet Pharma filed the final report of the work supported by this grant.In their response, the European Commission stated: “Hamlet Pharma’s Project has delivered exceptional results with significant immediate or potential impact.” The

Self Storage Group ASA - Acquisition of property in Kristiansund, Norway

(Oslo, March 17th 2023) Self Storage Group ASA (Self Storage Group, OSE:SSG) has entered into an agreement to acquire a property in Pilotveien in Kristiansund, Norway. The transaction has a value of NOK 16.5 million and the property has a potential lettable area of 1250 square meters. The facility is projected to open in Q1 2024 and will be operated under the City Self-Storage brand. “We are pleased to announce the acquisition of this property in Kristiansund. The property has a great location, close to the airport, and only a few kilometers from the city center. Following this

Bioretec postpones Annual General Meeting to a later date

Bioretec Ltd                        Company announcement   17 March 2023 at 4.45 EETBioretec Ltd’s Board of Directors has today decided to reschedule the date of the company´s Annual General Meeting (AGM) planned for April 14, 2023. The projected date of the AGM is May 26, 2023. The reason behind the postponement of the AGM is that the decision related to the US market approval of RemeOs™ -trauma screw is expected to arrive during April 2023 in accordance with the announcement published by the company on January 3, 2023. The outcome of that decision is expected to reach all the company´s

Director/PDMR Shareholding

17 March 2023 IOG plc Director/PDMR Dealings IOG plc ("IOG", or "the Company"), (AIM: IOG.L), announces that certain Directors and persons discharging managerial responsibilities ("PDMRs") of the Company have purchased in the market a total of 744,180 ordinary shares of 1p each ("Ordinary Shares") at an average price of 4.525p per Ordinary Share, equating to aggregate value of £33,671.32, as follows: Director/ Role Number of Resultant Resultant percentage of issued Ordinary number of share capital beneficially held PDMR Shares

Länsförsäkringar Alliance: Annual Review and Annual Reports 2022

Länsförsäkringar Alliance Annual Review and Annual Reports regarding; · Länsförsäkringar AB, · Länsförsäkringar Bank AB and · Länsförsäkringar Hypotek AB for the financial year 2022 are now available in English on Länsförsäkringar's website. Financial reports (lansforsakringar.se)    For further information, please contact: Anna Glennmar, Investor Relations Länsförsäkringar AB anna.glennmar@lansforsakringar.se, +46 (0)8-588 417 42, +46 (0)72-141 44 08

TF Bank publishes the 2022 Annual and Sustainability Report

The Board of Directors and CEO hereby present the 2022 Annual and Sustainability Report as well as the risk and capital adequacy report for TF Bank AB (publ). The documents have been published at www.tfbankgroup.com. “Credit Cards is by far our fastest growing segment and the loan portfolio increased by 79 % in local currencies during 2022. We have seen a positive trend in the segments profitability during the year.” – Mattias Carlsson, CEO For further information, please contact:Mikael Meomuttel, CFO and Head of Investor Relations +46 (0)70 626 95 33 TF Bank in briefTF Bank

NoHo Partners Plc: Managers' transactions (Niemi)

NoHo Partners PlcMANAGERS' TRANSACTIONS 17.3.2023 16:00NoHo Partners Plc: Managers' transactions (Niemi) Person subject to the notification requirementName: Hanna-Stiina NiemiPosition: Closely associated person (1):Person Discharging Managerial Responsibilities In IssuerName: Mika NiemiPosition: Member of the BoardIssuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 27511/4/6____________________________________________Transaction date: 2023-03-15Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHARE

Kyoto Group AS: Change to the Board of Directors

Oslo, Norway 17 March 2023 - Kyoto Group has been informed by Norsk Hydro that thermal energy storage is outside of its current strategic growth areas, and its holding in Kyoto will therefore be considered a financial investment rather than a strategic one. Consequently, Board member Ivar Valstad will today withdraw from the Board of Directors of Kyoto Group.The changed status of Hydro’s investment in Kyoto Group does not affect the ongoing commercial cooperation with Hydro Rein that was announced last year. “I would like to thank Ivar for his contributions to Kyoto and look forward to

Bioretec Ltd’s Annual Report and Financial Statements 2022 are published

Bioretec Ltd                       Company announcement      17 March 2023 at 3:15 p.m. EETBioretec Ltd has today published its 2022 Annual Report, Report by the Board of Directors, and Financial Statements. The publications are attached to this release and also available in Finnish and English on the company’s website at www.bioretec.com/investors/investors-in-english/reports-and-presentations. Further inquiries: Timo Lehtonen, CEO, +358 50 433 8493Johanna Salko, CFO, +358 40 754 8172  Certified advisor: Nordic Certified Adviser AB, +46 70 551 67 29 Information about

Audientes A/S – update of financial calendar for 2023

Company announcement no. 06-2023March 17, 2023 Audientes A/S (CVR 36047631) is announcing an update in its financial calender for 2023 to align activities and allow some members of the recently appointed Board of Directors to develop an informed view of the company, risk management and corporate governance matters prior to completion and approval of the Annual Report for 2022.First, the publication date of the Annual Report for 2022 is now moved from 23 March, 2023 to 13 April, 2023, to allow some members of the recently appointed Board of Directors sufficient time to review and

Stayble Therapeutics AB publishes prospectus relating to the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, CANADA, NEW ZEELAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, RUSSIA, BELARUS OR IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION OR WOULD REQUITE FURTHER REGISTRATION OR OTHER MEASURES ABOVE WHAT IS REQUIRED BY SWEDISH LAW. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. NB: This is an English convenience translation of this press release. In case of any discrepancy, the

Trading Update and New Funding

Following an assessment of preliminary results for the first two months of Q1 2023 and updated forecast numbers for Q1 and Q2, Ayima Group has determined it is necessary to make an announcement regarding current trading conditions. The first two months of the quarter have seen a significant reduction in profitability, due to extraordinary delays in routine contract renewals for long-term clients and some client terminations. Several clients affected have quoted unease about macroeconomic conditions such as inflation and downturns in the tech industry and have been reluctant to commit

Wicket Gaming´s Board of Directors has decided on a directed issue of units to underwriters in connection with the completed rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, CANADA, HONG KONG OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.  Wicket Gaming AB ("Wicket Gaming" or the "Company") has, as previously announced, completed the rights issue of units which the extraordinary general meeting decided on January 4, 2023 (the "Rights Issue"). In accordance with the underwriting agreements, Wicket Gaming'

Eevia Health Plc receives a 146 KSEK / 13 KEUR sales order for a bilberry extract

Eevia Health Plc, (”Eevia” or ”The Company”), has received sales order from Taiwan of c. 13 KEUR for an organically certified bilberry extract.The Taiwanese customer is an important and competitive distributor of ingredients and nutritional supplements in Taiwan. The distributor has a professional approach to quality and a strong presence in the market. The sales value to Eevia of this new order is c. KEUR 13 EUR. The product is Eevia’s branded ingredient Feno-Myrtillus® 25 Organic, which is a highly concentrated and organically certified bilberry extract with 25% anthocyanins. There

Fetch.ai Surges 550% as CEO Reveals How its Tech Will Create New Economy

Friday March 17th 2023 – Humayun Sheikh, CEO of AI-based blockchain project Fetch.ai, spoke exclusively to Cryptonews  about how a new AI bot framework – Autonomous Economic Agent (AEA) – will create a new economy. The interview, conducted by cryptonews.com reporter Sam Cooling, comes after Fetch.ai saw its token, $FET, surge by 550% in February – coinciding with an increase in interest in AI technology following the rise of ChatGPT and Google Bard. Sheikh explains why he believes the AEA framework will drive ecosystem growth by enabling the deployment

Scandinavian ChemoTech participates and presents at the LSI Emerging Medtech Summit in California, USA

Scandinavian ChemoTech and CEO Mohan Frick will present the company's tumor-specific electroporation (TSE) at the LSI Emerging Medtech Summit 2023 in California, USA. The event brings together the medtech industry's top strategists, investors and innovators.The conference is an event where ChemoTech and other medical device companies will present their innovations to some of the biggest players and investors in the medtech field. Participants include Medtronic, Johnson & Johnson and Boston Scientific as well as representatives from institutional investors and Family Offices. The event is

Communicate scan results and impress your patients with Planmeca Imprex™

Planmeca is introducing a mobile scanning station to support dental professionals in intraoral scanning and patient communication. Designed to fit any clinical setup, the Planmeca Imprex™ scanning station for Planmeca Emerald® S intraoral scanner ensures ergonomic working positions and allows visualising the oral health conditions and treatment plans to patients. Planmeca Imprex™ mobile scanning station allows dental professionals to impress their patients with high-quality digital impressions. The portable scanning station with a 15’’ touch screen can be moved freely close to any

Platzer’s Annual Report 2022 in English

Platzer’s Annual Report 2022 in English is now published on our website platzer.se , where it can also be downloaded.The Annual General Meeting of Platzer Fastigheter Holding AB (publ) will take place on Thursday, 23 March, 2023. Platzer Fastigheter Holding AB (publ) For further information please contact:P-G Persson, CEO, Platzer, tel:  +46(0)734-11 12 22Fredrik Sjudin, CFO, Platzer, tel: +46(0)721-27 77 78 This information is information that Platzer Fastigheter Holding AB (publ) is obliged to make public pursuant to the

Immunovia publishes prospectus relating to the rights issue

NOT FOR PUBLICATION, RELEASE DISSEMINATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SWITZERLAND, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER STATE, TERRITORY OR JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS DOCUMENT DOES NOT CONSTITUTE AN OFFER OF OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN IMMUNOVIA AB (PUBL). FOR MORE INFORMATION, SEE THE SECTION IMPORTANT INFORMATION BELOW.LUND, SWEDEN – Immunovia AB (publ) ("

Vianode selected as candidate for EU IPCEI grant

Vianode has been selected as one of five Norwegian candidates for an EU IPCEI grant, following the government’s and Minister of Trade and Industry Jan Christian Vestre’s decision to enroll Norway in IPCEI EuBatIn.Vianode builds industrial leadership in advanced battery materials, by producing sustainable anode materials with significantly lower emissions compared to conventional production. To succeed in building industry leadership in advanced battery materials, the company depends on competitive framework conditions. The Norwegian participation in IPCEI EUBatIn represents a major step

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release March 17, 2023 at 1:30 p.m. Nokian Tyres has received an announcement from JPMorgan Chase & Co. on March 16, 2023, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total holding in Nokian Tyres shares and voting rights owned by the funds and accounts managed by JPMorgan Chase & Co. fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on March 15, 2023. Total positions of person(s) subject to the notification obligation: +---

There are no items matching the current filter
There are no more items matching the current filter
Back to top